Cargando…
Radiosensitization of C3H Mouse Mammary Tumours by a 2-Nitroimidazole Drug
Local tumour control has been determined at 150 days after single doses of 240 kV x-rays given with or without 1 mg/g body weight of the hypoxic cell radiosensitizer Ro-07-0582. The dose required to control 50% of the tumours (TCD50) was reduced from 4380 to 2410 rad, yielding an enhancement ratio o...
Autores principales: | Sheldon, P. W., Foster, J. L., Fowler, J. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1974
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009326/ https://www.ncbi.nlm.nih.gov/pubmed/4451633 |
Ejemplares similares
-
In vivo assessment of basic 2-nitroimidazole radiosensitizers.
por: Williams, M. V., et al.
Publicado: (1982) -
Radiobiology of the C3H Mouse Mammary Carcinoma: Comparative Radiosensitivity of the Tumour Prior to Implantation and of the Established Tumour In Situ
por: Cohen, A., et al.
Publicado: (1953) -
Modest radiosensitization of solid tumours in C3H mice by the hypoxic cell radiosensitizer NDPP.
por: Sheldon, P. W., et al.
Publicado: (1975) -
Radiobiology of the C3H Mouse Mammary Carcinoma: Effect of Immunogenetic Factors on the Radiosensitivity of the Tumour Treated In Situ
por: Cohen, A., et al.
Publicado: (1954) -
Effect of lipophilicity of nitroimidazoles on radiosensitization of hypoxic bacterial cells in vitro.
por: Anderson, R. F., et al.
Publicado: (1979)